Abstract
The 22q11.2 duplication is a variably penetrant copy number variant (CNV) associated with a broad spectrum of clinical manifestations including autism spectrum disorders (ASD), and epilepsy. Here, we report on pathogenic HUWE1 and KIF1A mutations in two severely affected ASD/ID participants carrying a 22q11.2 duplication. Based on previous studies, this CNV was originally considered as disease-causing. Yet, owing to their clinical severity, the participants were further investigated by next generation sequencing and eventually found to carry pathogenic mutations in HUWE1 and KIF1A respectively. We suggest giving consideration to additive effect of 22q11.2 duplication and pathogenic mutations when clinical presentation is either unusually severe or associated with atypical features. Caution should be exercised when delivering genetic counseling for variably penetrant CNVs, as uncertain penetrance of this CNV may lead to ignore additive pathogenic mutations. Systematic panel or exome sequencing of known ASD genes should be recommended when counseling families of patients carrying variably penetrant CNV.
This is a preview of subscription content, log in via an institution to check access.
References
Bosshard, M., Aprigliano, R., Gattiker, C., et al. (2017). Impaired oxidative stress response characterizes HUWE1-promoted X-linked intellectual disability. Scientific Reports, 7(1), 15050. https://doi.org/10.1038/s41598-017-15380-y.
Cheon, C. K., Lim, S.-H., Kim, Y.-M., et al. (2017). Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Scientific Reports, 2(1), 12527. https://doi.org/10.1038/s41598-017-12999-9. 7) .
Clements, C. C., Wenger, T. L., Zoltowski, A. R., et al. (2017). Critical region within 22q11.2 linked to higher rate of autism spectrum disorder. Molecular Autism, 27(8), 58. https://doi.org/10.1186/s13229-017-0171-7.
Friez, M. J., Brooks, S. S., Stevenson, R. E., et al. (2016). HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: The results of an X-chromosome exome sequencing study. BMJ Open, 6(4), e009537. https://doi.org/10.1136/bmjopen-2015-009537.
Girirajan, S., Rosenfeld, J. A., Coe, B. P., et al. (2012). Phenotypic heterogeneity of genomic disorders and rare copy number variants. The New England Journal of Medicine, 367(14), 1321–1331.
Grati, F. R., Molina Gomes, D., Ferreir, J. C. P. B., et al. (2015). Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenatal Diagnosis, 35(8), 801–809.
Lee, J. R., Srour, M., Kim, D., et al. (2015). De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Human Mutation, 36(1), 69–78.
Maya, I., Sharony, R., Yacobson, S., et al. (2017). When genotype is not predictable of phenotype: Implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations. Genetics in Medicine. https://doi.org/10.1038/gim.2017.89.
Piccione, M., Vecchio, D., Cavani, S., et al. (2011). The first case of myoclonic epilepsy in a child with a de novo 22q11.2 microduplication. American Journal of Medical Genetics Part A, 155A(12), 3054–3059.
Schaefer, G. B., Mendelsohn, N. J., & for the Professional Practice and Guidelines Committee. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine, 15(5), 399–407.
Valvo, G., Novara, F., Brovedani, P., et al. (2012). 22q11.2 microduplication syndrome and epilepsy with continuous spikes and waves during sleep (CSWS). A case report and review of the literature. Epilepsy & Behavior, 25(4), 567–572.
Vorstman, J. A. S., Parr, J. R., Moreno-De-Luca, D., et al. (2017). Autism genetics: Opportunities and challenges for clinical translation. Nature Reviews Genetics, 18(6), 362–376.
Wenger, T. L., Miller, J. S., DePolo, L. M., et al. (2016). 22q11.2 duplication syndrome: Elevated rate of autism spectrum disorder and need for medical screening. Molecular Autism, 6(7), 27. https://doi.org/10.1186/s13229-016-0090-z.
Acknowledgments
Pr Nicolas Franck for his advice and le Vinatier Hospital for its support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demily, C., Lesca, G., Poisson, A. et al. Additive Effect of Variably Penetrant 22q11.2 Duplication and Pathogenic Mutations in Autism Spectrum Disorder: To Which Extent Does the Tree Hide the Forest?. J Autism Dev Disord 48, 2886–2889 (2018). https://doi.org/10.1007/s10803-018-3552-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-018-3552-7